Date	Event
21/03/2016	Dossier received by EFSA: L‐Histidine monohydrochloride monohydrate – 98%, produced by E. coli. Submitted by Kyowa Hakko Europe GmbH.
22/04/2016	Reception mandate from the European Commission
22/07/2016	Application validated by EFSA – Start of the scientific assessment
14/10/2016	Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation (EC) No 1831/2003 – Scientific assessment suspended. Issues: characterisation of the additive and the production strain, production process, stability, safety.
21/07/2017	Reception of supplementary information from the applicant ‐ Scientific assessment re‐started
22/09/2017	Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation (EC) No 1831/2003 – Scientific assessment suspended. Issues: characterisation of the production strain.
16/10/2017	Reception of supplementary information from the applicant ‐ Scientific assessment re‐started
29/11/2017	Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation (EC) No 1831/2003 – Scientific assessment suspended. Issues: characterisation of the additive and of the production strain; safety for the target species.
23/01/2018	Reception of supplementary information from the applicant ‐ Scientific assessment re‐started
18/03/2020	Opinion adopted by the FEEDAP Panel. End of the Scientific assessment